Apart from their antimicrobial effect, AMPs have been showntohave therapeutic potential for the treatment of skin and other epithelialinjuries.21 Two examples include talactoferrin,which has been shown to stimulate wound healing, and pexiganan, whichwas developed for the topical treatment of diabetic foot ulcers.22,23 Another beneficial factor regarding AMPs in wound management istheir target selectivity. The gene discussed is ADSL; the disease is diabetic foot.